Overview Financials News + Filings Key Docs Charts Ownership Insiders |
NATIONAL RESEARCH CORP (NRC)
|
Add to portfolio |
|
|
Price: |
$42.25
| | Metrics |
OS: |
24.6
|
M
| |
|
|
Market cap: |
$1.04
|
B
| |
|
|
Net cash:
|
$2.53
|
M
| |
$0.10
|
per share
|
EV:
|
$1.04
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$54.6
|
M
| |
19.0
|
x EV/EBITDA
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 151.6 | 148.0 | 133.3 | 128.0 | 119.7 | 117.6 | 109.4 | 102.3 |
Revenue growth | 2.4% | 11.0% | 4.1% | 6.9% | 1.8% | 7.5% | 6.9% | 3.5% |
Cost of goods sold | 57.0 | 52.4 | 49.2 | 46.4 | 47.6 | 49.1 | 45.6 | 44.6 |
Gross profit | 94.5 | 95.6 | 84.1 | 81.5 | 72.1 | 68.5 | 63.8 | 57.7 |
Gross margin | 62.4% | 64.6% | 63.1% | 63.7% | 60.2% | 58.3% | 58.3% | 56.4% |
Selling, general and administrative | 42.7 | 39.0 | 34.4 | 33.0 | 31.4 | 29.7 | 28.4 | 27.2 |
EBITA | 46.7 | 50.6 | 43.0 | 43.4 | 35.9 | 34.8 | 31.9 | 27.4 |
EBITA margin | 30.8% | 34.2% | 32.3% | 33.9% | 30.0% | 29.6% | 29.1% | 26.8% |
Amortization of intangibles | 0.2 | 0.3 | 0.3 | 0.4 | 0.7 | 0.6 | 0.7 | 1.0 |
EBIT | 46.5 | 50.3 | 42.7 | 43.0 | 35.3 | 34.2 | 31.2 | 26.4 |
EBIT margin | 30.7% | 34.0% | 32.0% | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% |
Pre-tax income | 42.8 | 48.6 | 41.5 | 40.5 | 34.7 | 34.3 | 31.4 | 27.4 |
Income taxes | 11.0 | 11.2 | 4.2 | 8.1 | 4.7 | 11.3 | 10.8 | 9.8 |
Tax rate | 25.7% | 22.9% | 10.1% | 20.0% | 13.4% | 33.1% | 34.6% | 35.6% |
Net income | 31.8 | 37.5 | 37.3 | 32.4 | 30.0 | 22.9 | 20.5 | 17.6 |
Net margin | 21.0% | 25.3% | 28.0% | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% |
|
Diluted EPS | $1.27 | $1.46 | $1.45 | $1.26 | $1.07 | $0.91 | $0.83 | $0.72 |
Shares outstanding (diluted) | 25.1 | 25.6 | 25.7 | 25.7 | 28.1 | 25.2 | 24.6 | 24.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|